Vural Osman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vural Osman has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Karakeci
Department of Urology, Fırat University, Elazığ, Turkey
1 shared publication - Ahmet Keles
Istanbul Medeniyet University
1 shared publication - Emel Sabaz Karakeci
Department of Physical Medicine and Rehabilitation, Fethi Sekin City Hospital, Health Sciences University, Elazig, Türkiye
1 shared publication - İrFan Orhan
Department of Urology, Fırat University Hospital, Elazığ, Turkey
1 shared publication - Tuncay Kuloğlu
Department of Histology and Embryology, Firat University Hospital, Elazig, Turkey
1 shared publication - Tunç Ozan
Firat University, School of Medicine
1 shared publication
Latest Publications
- Open Access
- 1 January 2024
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. XXXIV (1) , 1-7
Evaluating Adropine levels in kidney tissue after Methotrexate treatment in rats: a prospective experimental study
In this study, it was aimed to investigate Adropin levels in kidney tissues after Methotrexate (MTX) administration to identify potential changes following administration of agents with antioxidant/anti–inflammatory potential. Twenty four adult rats male albino Wistar rats were used in this study, and randomly divided into four groups. Control: These rats did not receive any treatment during the 14–day (d) experiment. N–acetylcysteine (NAC): These rats were administered 100 mg·kg-1·day-1 NAC intraperitoneally (i.p.) for 14 d. MTX: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study. MTX+ NAC: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study, and the rats were given 100 mg·kg-1·day-1 NAC i.p. for 14 d. Total antioxidant, and serum Adropin levels were found to be the lowest in the MTX group while the oxidant levels were significantly lower in the MTX group than in the MTX+NAC group (P<0.001). TUNEL positivity was similar among the groups, and no significant differences were observed. It was considered that these findings have shed light on the role of Adropin in the development of kidney failure following MTX administration.
- 1 January 2024
- Published by Universidad del Zulia in Revista Científica de la Facultad de Ciencias Veterinarias
- Vol. XXXIV (1) , 1-7
Open AccessEvaluating Adropine levels in kidney tissue after Methotrexate treatment in rats: a prospective experimental study
In this study, it was aimed to investigate Adropin levels in kidney tissues after Methotrexate (MTX) administration to identify potential changes following administration of agents with antioxidant/anti–inflammatory potential. Twenty four adult rats male albino Wistar rats were used in this study, and randomly divided into four groups. Control: These rats did not receive any treatment during the 14–day (d) experiment. N–acetylcysteine (NAC): These rats were administered 100 mg·kg-1·day-1 NAC intraperitoneally (i.p.) for 14 d. MTX: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study. MTX+ NAC: A single dose of 20 mg·kg-1 MTX was administered i.p. at the beginning of the study, and the rats were given 100 mg·kg-1·day-1 NAC i.p. for 14 d. Total antioxidant, and serum Adropin levels were found to be the lowest in the MTX group while the oxidant levels were significantly lower in the MTX group than in the MTX+NAC group (P<0.001). TUNEL positivity was similar among the groups, and no significant differences were observed. It was considered that these findings have shed light on the role of Adropin in the development of kidney failure following MTX administration.